Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline

AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline

LEAD Therapeutics discovers orally available PARP inhibitor

LEAD Therapeutics discovers orally available PARP inhibitor

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

PPD, Janssen Pharmaceutica to develop therapeutic compounds for IBS and bacterial infections

PPD, Janssen Pharmaceutica to develop therapeutic compounds for IBS and bacterial infections

4SC raises funds for further development of its current product pipeline

4SC raises funds for further development of its current product pipeline

Fate Therapeutics announces the completion of $30 million Series B financing

Fate Therapeutics announces the completion of $30 million Series B financing

Potential of the European Biomarker Analysis Market to be the focus at upcoming Analyst Briefing

Potential of the European Biomarker Analysis Market to be the focus at upcoming Analyst Briefing

Amorfix Life Sciences reports operating results for the three months ended September 30, 2009

Amorfix Life Sciences reports operating results for the three months ended September 30, 2009

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Stapled Peptides directly inhibit the Notch transcription factor complex

Stapled Peptides directly inhibit the Notch transcription factor complex

Stapled Peptides can inhibit key intracellular biological targets, says new research

Stapled Peptides can inhibit key intracellular biological targets, says new research

Scientists find way to disarm "undruggable" protein; discovery lays foundation for new kind of cancer therapy

Scientists find way to disarm "undruggable" protein; discovery lays foundation for new kind of cancer therapy

Envoy Therapeutics secures loan from Takeda Research Investment

Envoy Therapeutics secures loan from Takeda Research Investment

Duke University, Jubilant Organosys sign letter of intent for drug development partnership

Duke University, Jubilant Organosys sign letter of intent for drug development partnership

New imagining technique may yield better antiviral and anti-cancer drugs

New imagining technique may yield better antiviral and anti-cancer drugs

Labcyte to receive $5.5 million from Hercules Technology Growth Capital

Labcyte to receive $5.5 million from Hercules Technology Growth Capital

AMRI reports $47.7 million total revenue for the third quarter of 2009

AMRI reports $47.7 million total revenue for the third quarter of 2009

Caliper Discovery Alliances and Services receives a $1.8M funding commitment for the EPA's ToxCast program

Caliper Discovery Alliances and Services receives a $1.8M funding commitment for the EPA's ToxCast program

Locus Pharmaceuticals creates a new division, Ansaris

Locus Pharmaceuticals creates a new division, Ansaris

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.